We are monitoring the impact of COVID-19 & Recession alarm on APAC Antacid Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Antacid Market Research Report - Segmented By Drug Class, Formulation Type, Distribution Channel & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends & Growth Forecasts (2022 to 2027)

Published: January, 2022
ID: 2268
Pages: 145

APAC Antacid Market Size & Growth (2022 to 2027):

As per the research report, the Size of the APAC Antacid Market was valued at USD 3.04 billion in 2022 and is estimated to reach USD 3.69 billion by 2027, to reach at a CAGR of 4% during the forecast period 2022 to 2027.

Over-the-counter digestive products are in high demand, reflecting the growth of the global antacid market. In addition, self-medication is on the rise, contributing to the development of over-the-counter digestive products.

The demand for Antacids is likely to increase dramatically as they neutralize acidity. Nonetheless, about one-third of the adult population in the United States suffers from GERD, according to a study by the American Gastroenterological Association published in the International Functional Foundation in February 2017.

Through digital advertisements and campaigns, the counter drugs are becoming more and more popular, generating growth opportunities for the antacids market. There is a growing need to treat gastrointestinal problems worldwide, creating growth opportunities. The ever-increasing geriatric population drives market demand, as acidity issues are more common in the elderly. 

Sedentary lifestyles also contribute to several acidity-related issues, positively impacting the market. Poor lifestyle choices involve deskbound jobs, poor sleep quality, and irregular dietary habits, which increase the stomach's acidity level and lead to gastroesophageal reflux disease. The market for antacids is developing due to the rising need for early diagnosis among individuals. Increased focus on releasing high-quality pharmaceuticals and a high manufacturing pace substantially impact market demand. 

The rise of the antacids industry is aided by rising disposable income in metropolitan regions. In addition, the rising popularity of self-medication is accelerating the market's expansion. The demand for antacids is also being fueled by a growing knowledge of the early indications of gastrointestinal illnesses. 

Some side effects, including constipation, laxative effect, and allergic responses, will likely slow down the global antacids market's growth pace. Furthermore, individuals with specific medical conditions are more susceptible to adverse effects. For example, people with heart disease are also likely to experience problems due to the high sodium content in antacids. The market's growth is being stifled as a result of this.

This research report on the APAC Antacid Market has been segmented and sub-segmented into the following categories.

By Drug Class: 

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-motility Agents

By Formulation Type: 

  • Tablet
  • Liquid
  • Powder

By Distribution Channel: 

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Disease Indications:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Immunological Disorders
  • Other Diseases

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia Pacific is predicted to be the most significant and fastest-growing regional market over the forecast period. Antacids are commonly used to treat symptoms like excessive heartburn, sore stomach, acid reflux, and stomach discomfort. The Asia Pacific market for medicine delivery services consists of China, India, Japan, South Korea, Australia, and the APAC region. 

The China Antacid market and Indian Antacid market are expected to be the fastest-growing markets over the forecast period. Japan, Australia, and South Korea are the following countries in line. Due to enormous unmet patient demands, the availability of effective treatment options, more disposable income, and consumer knowledge of these items' availability. 

These nations are also likely to play an essential role in the APAC Antacid market in the coming years. It is related to the region's aging population, rapid urbanization and industrialization, rising disposable income, excellent governmental and private sector R&D investment, and increased consumer awareness. According to Asian Development Bank forecasts, Asia's population of individuals aged 60 and more will double by 2050. All reports suggest a steady growth in APAC Antacid Market.

KEY MARKET PLAYERS

Notable companies dominating in the Asia Pacific Antacid Market profiled in this report are Sun Pharma, Digene (Abbott India), Pudin Hara (Dabur), and GlaxoSmithKline plc, Abbott Laboratories, Pfizer, Inc, Gelusil (Pfizer).,

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class                   

                                5.1.1 Introduction           

                                5.1.2 Proton Pump Inhibitors     

                                5.1.3 H2 Antagonist        

                                5.1.4 Pro-motility agents              

                                5.1.5 Acid Neutralizers  

                                5.1.6 Y-o-Y Growth Analysis, By Drug Class          

                                5.1.7 Market Attractiveness Analysis, Drug Class              

                                5.1.8 Market Share Analysis, By Drug Class         

                5.2 Formulation Type                    

                                5.2.1 Introduction           

                                5.2.2 Tablet        

                                5.2.3 Liquid        

                                5.2.4 Powder    

                                5.2.5 Y-o-Y Growth Analysis, By Formulation Type            

                                5.2.6 Market Attractiveness Analysis, By Formulation Type          

                                5.2.7 Market Share Analysis, By Formulation Type           

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Retail pharmacies 

                                5.3.4 Other        

                                5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.6 Market Attractiveness Analysis, By Distribution Channel   

                                5.3.7 Market Share Analysis, By Distribution Channel      

                5.4 Disease Indications 

                                5.4.1 Introduction           

                                5.4.2 Cancer      

                                5.4.3 CardiovascularDisorders    

                                5.4.4 Neurological Disorders       

                                5.4.5 Immunological Disorders  

                                5.4.6 Other Diseases      

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications         

                                5.4.8  Market Attractiveness Analysis, By Disease Indications      

                                5.4.9  Market Share Analysis, By Disease Indications       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Drug Class

                                                6.1.3.3 By Formulation Type

                                                6.1.3.4 By Distribution Channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Drug Class

                                                6.1.4.3 By Formulation Type

                                                6.1.4.4 By Distribution Channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Drug Class

                                                6.1.5.3 By Formulation Type

                                                6.1.5.4 By Distribution Channel

                6.2 Asia-Pacific                 

                                6.2.1 Introduction           

                                6.2.2 China         

                                6.2.3 India          

                                6.2.4 Japan         

                                6.2.5 Australia   

                                6.2.6 South Korea           

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Glaxo Smith                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Abbott Laboratories               

                8.3 Pfizer Inc                     

                8.4 Sun Pharmaceuticals                              

                8.5 Consumer Health                     

                8.6 Dabur                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                 

  1. Asia Pacific Antacid Market, By Drug Class, From 2022 - 2027 (USD Billion)
  2. Asia Pacific Proton Pump Inhibitors Market, By Region, From 2022 - 2027 (USD Billion)
  3. Asia Pacific H2 Antagonist Market, By Region, From 2022 - 2027 (USD Billion)
  4. Asia Pacific Acid Neutralizers Market, By Region, From 2022 - 2027 (USD Billion)
  5. Asia Pacific Pro-Motility Agents Market, By Region, From 2022 - 2027 (USD Billion)
  6. Asia Pacific Antacid Market, By Formulation type, From 2022 - 2027 (USD Billion)
  7. Asia Pacific Tablet Market, By Region, From 2022 - 2027 (USD Billion)
  8. Asia Pacific Liquid Market, By Region, From 2022 - 2027 (USD Billion)
  9. Asia Pacific Powder Market, By Region, From 2022 - 2027 (USD Billion)
  10. Asia Pacific Antacid Market, By Distribution Channel, From 2022 - 2027 (USD Billion)
  11. Asia Pacific Hospital Pharmacies Market, By Region, From 2022 - 2027 (USD Billion)
  12. Asia Pacific Retail Pharmacies Market, By Region, From 2022 - 2027 (USD Billion)
  13. Asia Pacific Others Market, By Region, From 2022 - 2027 (USD Billion)
  14. Japan Antacid Market, By Drug Class, From 2022 - 2027 (USD Billion)
  15. Japan Antacid Market, By Formulation type, From 2022 - 2027 (USD Billion)
  16. Japan Antacid Market, By Distribution Channel, From 2022 - 2027 (USD Billion)
  17. China Antacid Market, By Drug Class, From 2022 - 2027 (USD Billion)
  18. China Antacid Market, By Formulation type, From 2022 - 2027 (USD Billion)
  19. China Antacid Market, By Distribution Channel, From 2022 - 2027 (USD Billion)
  20. India Antacid Market, By Drug Class, From 2022 - 2027 (USD Billion)
  21. India Antacid Market, By Formulation type, From 2022 - 2027 (USD Billion)
  22. India Antacid Market, By Distribution Channel, From 2022 - 2027 (USD Billion)
  23. Australia Antacid Market, By Drug Class, From 2022 - 2027 (USD Billion)
  24. Australia Antacid Market, By Formulation type, From 2022 - 2027 (USD Billion)
  25. Australia Antacid Market, By Distribution Channel, From 2022 - 2027 (USD Billion)
  26. South Korea Antacid Market, By Drug Class, From 2022 - 2027 (USD Billion)
  27. South Korea Antacid Market, By Formulation type, From 2022 - 2027 (USD Billion)
  28. South Korea Antacid Market, By Distribution Channel, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample